Thermal behaviour and antimicrobial assay of some new zinc(II) 2-aminobenzoate complex compounds with bioactive ligands

New zinc(II) 2-aminobenzoate complexes with general formula Zn(2-NH 2 benz) 2 (L) 2 (where 2-NH 2 benz is 2-aminobenzoate, and L is phenazone, N -methylnicotinamide, nicotinamide and isonicotinamide) were prepared and characterized by elemental analysis and by FTIR spectroscopy. The stability and th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of thermal analysis and calorimetry 2015-04, Vol.120 (1), p.73-83
Hauptverfasser: Krajníková, Annamária, Rotaru, Andrei, Győryová, Katarína, Homzová, Katarína, Manolea, Horia Octavian, Kovářová, Jana, Hudecová, Daniela
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:New zinc(II) 2-aminobenzoate complexes with general formula Zn(2-NH 2 benz) 2 (L) 2 (where 2-NH 2 benz is 2-aminobenzoate, and L is phenazone, N -methylnicotinamide, nicotinamide and isonicotinamide) were prepared and characterized by elemental analysis and by FTIR spectroscopy. The stability and thermal behaviour of the compounds were studied by thermal analysis techniques (TG/DTG, DTA), and the decomposition reactions were proposed. The decomposition of the studied compounds is always a multistep process, when after the release of the bioactive ligand, 2-aminobenzenecarbaldehyde, 2-aminobenzene and carbon dioxide were evolved. The solid intermediate compounds were confirmed by FTIR spectroscopy, and the volatile products were identified by mass spectrometry. The final solid product of thermal decompositions was zinc oxide, which was confirmed by XRD and FTIR analysis. The non-isothermal kinetic investigation of Zn(2-NH2benz) 2 (mnad) 2 decomposition in air was performed by means of isoconversional methods, for a better understanding of the undergoing processes. The antimicrobial assay was carried out comparatively for the investigated compounds; they have higher biological activity towards Staphylococcus aureus , Escherichia coli and Candida albicans in comparison with zinc(II) 4-bromobenzoates.
ISSN:1388-6150
1588-2926
1572-8943
DOI:10.1007/s10973-014-4212-6